3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
10
Head & Neck
2
Genitourinary
2
Tumor-Agnostic
1
Thoracic
1
Other hematologic neoplasm
1
Other
1
Gynecologic
1
Conditions
Gynecologic Cancer
1
Interventions
Paclitaxel
79
Cisplatin
72
Carboplatin
72
Bevacizumab
29
Radiotherapy
27
Brachytherapy
23
Hyperthermic Intraperitoneal Chemotherapy
20
Drug Therapy
20
olaparib
19
Gemcitabine
17
niraparib
16
apatinib
16
pembrolizumab
15
Surgical Procedures, Operative
15
liposomal doxorubicin
12
Cyclophosphamide
12
Surveys and Questionnaires
11
camrelizumab
10
Taxes
10
Neoadjuvant Therapy
10
fludarabine
9
anlotinib
9
Etoposide
9
Blood Specimen Collection
9
Topotecan
8
Docetaxel
8
Sentinel Lymph Node Biopsy
7
Platinum
7
Injections
7
Cytoreduction Surgical Procedures
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Preoperative Exercise
×
Gynecologic
×
Clear all
NCT04596800
2023-10-31
PROPER
Instituto Brasileiro de Controle do Cancer
Phase 3
Unknown
194 enrolled